Salvage therapy for relapsed or refractory diffuse large B-cell lymphoma: impact of prior rituximab.
Sud
Rohit
R
Friedberg
Jonathan W
JW
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D019008:Drug Resistance, Neoplasm; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000628:therapy*; D000069283:Rituximab; D016879:Salvage Therapy / Q000379:methods*
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab